search
Back to results

Bilberry Fruit and Black Rice Derived Anthocyanins on Lipid Status

Primary Purpose

Hyperlipidemia

Status
Completed
Phase
Not Applicable
Locations
United Kingdom
Study Type
Interventional
Intervention
Delphinidin type anthocyanins
Cyanidin type anthocyanins
Placebo
Sponsored by
Quadram Institute Bioscience
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Hyperlipidemia

Eligibility Criteria

45 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Men and women ≥ 45 years of age
  • Total cholesterol ≥ 5.0 mmol/L

Exclusion Criteria:

  • Smokers (or stopped smoking for less than 3 months)
  • Medical conditions that are judged to affect the primary outcome measure for this study or which may compromise the well-being of the participant e.g. diabetes.
  • Prescribed and non-prescribed medications that may affect the primary outcome measure for this study e.g. lipid lowering therapy
  • Dietary supplements judged to affect the study data unless the participant is willing to discontinue them for 4 weeks preceding the start of the study and for the duration of the study
  • Use foods for lowering cholesterol e.g. benecol, flora proactive
  • Regular/recent use of colonic irrigation or other bowel cleansing techniques.
  • Intend to change the normal use of pre or probiotics during the study (only applies to those collecting faecal samples)
  • Bowel movements ≤ 3 times per week (only applies to those collecting faecal samples)
  • Gastro-intestinal diseases (excluding hiatus hernia unless symptomatic or study intervention/procedure is contra-indicated).
  • Parallel participation in another research project which involves dietary intervention
  • Participation in another research project which has involved blood sampling within the last four months unless the total amount of combined blood from both studies does not exceed 470 ml.
  • Has donated or intends to donate blood within 16 weeks prior to or during the study period.
  • Any person related to or living with any member of the study team
  • Lack of capacity to provide written informed consent
  • Are pregnant or have been pregnant within the last 12 months

Sites / Locations

  • Quadram Institute Bioscience

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Active Comparator

Active Comparator

Placebo Comparator

Arm Label

Delphinidin type anthocyanins

Cyanidin type anthocyanins

Placebo

Arm Description

Bilberry extract

Black rice extract

No anthocyanins

Outcomes

Primary Outcome Measures

LDL cholesterol
Serum lipid status

Secondary Outcome Measures

Total/HDL cholesterol and triglycerides
Serum lipid status and faecal excretion of lipids
Cholesterol efflux capacity
Cholesterol metabolism
PON-1 activity
Cholesterol metabolism
Bile acids and derivatives
Plasma bile acid status and faecal excretion of bile acids
Glucose, fructosamine and insulin
glycaemic control
MicroRNA expression
MicroRNA's implicated in atherosclerosis, non-alcoholic fatty liver disease and reverse cholesterol transport

Full Information

First Posted
July 5, 2017
Last Updated
December 9, 2019
Sponsor
Quadram Institute Bioscience
search

1. Study Identification

Unique Protocol Identification Number
NCT03213288
Brief Title
Bilberry Fruit and Black Rice Derived Anthocyanins on Lipid Status
Official Title
The Effects of Bilberry Fruit and Black Rice Derived Anthocyanins on Lipid Status in Adults
Study Type
Interventional

2. Study Status

Record Verification Date
December 2019
Overall Recruitment Status
Completed
Study Start Date
September 25, 2017 (Actual)
Primary Completion Date
September 30, 2018 (Actual)
Study Completion Date
September 30, 2018 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Quadram Institute Bioscience

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The primary aim of this study is to directly compare the two major types of anthocyanins found in the diet (cyanidin-type and delphinidin-type) on lipid status in adults.
Detailed Description
Human intervention trials with anthocyanin-rich berry fruits/extracts such as whole strawberries, elderberry juice and whortleberry extracts, and purified anthocyanins from a mixture of blackcurrant and bilberry have been shown to beneficially alter biological markers for CVD risk, with beneficial effects on lipid profiles common across these studies. In a randomized 3 phase crossover study we aim to recruit 50 participants (men and women) aged 45 years or more with a higher than optimal blood cholesterol level to consume capsules containing (i) 320 mg anthocyanins derived from bilberry fruit (delphinidin type), (ii) 320 mg anthocyanins derived from black rice (cyanidin type) and (iii) a placebo control. Each treatment will be ingested for 28 days with a wash-out period of 4 weeks in-between. Blood samples will be collected at the start and end of each 28-day treatment period to assess lipid status. In a subset of participants we will also investigate the relationship between bilberry and black rice anthocyanin ingestion on RNA expression profiles that are known to be involved in atherosclerosis, non-alcoholic fatty liver disease and reverse cholesterol transport as well as faecal excretion of bile acids and lipids.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hyperlipidemia

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
55 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Delphinidin type anthocyanins
Arm Type
Active Comparator
Arm Description
Bilberry extract
Arm Title
Cyanidin type anthocyanins
Arm Type
Active Comparator
Arm Description
Black rice extract
Arm Title
Placebo
Arm Type
Placebo Comparator
Arm Description
No anthocyanins
Intervention Type
Dietary Supplement
Intervention Name(s)
Delphinidin type anthocyanins
Intervention Description
Bilberry extract containing Delphinidin type anthocyanins
Intervention Type
Dietary Supplement
Intervention Name(s)
Cyanidin type anthocyanins
Intervention Description
Black rice extract containing Cyanidin type anthocyanins
Intervention Type
Dietary Supplement
Intervention Name(s)
Placebo
Intervention Description
No anthocyanins
Primary Outcome Measure Information:
Title
LDL cholesterol
Description
Serum lipid status
Time Frame
28 days
Secondary Outcome Measure Information:
Title
Total/HDL cholesterol and triglycerides
Description
Serum lipid status and faecal excretion of lipids
Time Frame
28 days
Title
Cholesterol efflux capacity
Description
Cholesterol metabolism
Time Frame
28 days
Title
PON-1 activity
Description
Cholesterol metabolism
Time Frame
28 days
Title
Bile acids and derivatives
Description
Plasma bile acid status and faecal excretion of bile acids
Time Frame
28 days
Title
Glucose, fructosamine and insulin
Description
glycaemic control
Time Frame
28 days
Title
MicroRNA expression
Description
MicroRNA's implicated in atherosclerosis, non-alcoholic fatty liver disease and reverse cholesterol transport
Time Frame
28 days

10. Eligibility

Sex
All
Minimum Age & Unit of Time
45 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Men and women ≥ 45 years of age Total cholesterol ≥ 5.0 mmol/L Exclusion Criteria: Smokers (or stopped smoking for less than 3 months) Medical conditions that are judged to affect the primary outcome measure for this study or which may compromise the well-being of the participant e.g. diabetes. Prescribed and non-prescribed medications that may affect the primary outcome measure for this study e.g. lipid lowering therapy Dietary supplements judged to affect the study data unless the participant is willing to discontinue them for 4 weeks preceding the start of the study and for the duration of the study Use foods for lowering cholesterol e.g. benecol, flora proactive Regular/recent use of colonic irrigation or other bowel cleansing techniques. Intend to change the normal use of pre or probiotics during the study (only applies to those collecting faecal samples) Bowel movements ≤ 3 times per week (only applies to those collecting faecal samples) Gastro-intestinal diseases (excluding hiatus hernia unless symptomatic or study intervention/procedure is contra-indicated). Parallel participation in another research project which involves dietary intervention Participation in another research project which has involved blood sampling within the last four months unless the total amount of combined blood from both studies does not exceed 470 ml. Has donated or intends to donate blood within 16 weeks prior to or during the study period. Any person related to or living with any member of the study team Lack of capacity to provide written informed consent Are pregnant or have been pregnant within the last 12 months
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Paul Kroon
Organizational Affiliation
Quadram Institute Bioscience
Official's Role
Principal Investigator
Facility Information:
Facility Name
Quadram Institute Bioscience
City
Norwich
ZIP/Postal Code
NR4 7UA
Country
United Kingdom

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Bilberry Fruit and Black Rice Derived Anthocyanins on Lipid Status

We'll reach out to this number within 24 hrs